Related Experiment Video
Updated: Jun 3, 2026
11:22
Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue
Published on: August 17, 2016
Ambiguous assignment of release data in stability studies
1Flower Valley Consulting, Inc., Rockville, Maryland 20853, USA. wrf343@flowervalleyconsulting.com
Journal of Biopharmaceutical Statistics
|March 29, 2011
Summary
Improper use of release data in stability studies is common. This paper explores proper methods, finding an ad hoc procedure compares favorably with multiple imputation for stability data analysis.
Area of Science:
- Pharmaceutical Sciences
- Biostatistics
Background:
- Stability studies are crucial for drug shelf-life determination.
- Incorrect utilization of release data can compromise study integrity.
- Existing methods for handling release data in stability studies require evaluation.
Purpose of the Study:
- To investigate the proper application of release data in pharmaceutical stability studies.
- To compare the efficacy of different statistical methods for analyzing stability data.
- To identify a practical and effective approach for stability data analysis.
Main Methods:
- Exploration of the proper use of release data in stability studies.
- Determination and comparison of the maximum likelihood solution with multiple imputation and an ad hoc procedure.
- Statistical analysis of stability data under different methodological assumptions.
Main Results:
- The maximum likelihood solution was found to be impractical for stability data analysis.
- An ad hoc procedure demonstrated favorable comparison with multiple imputation.
- The study highlights the limitations of certain statistical approaches in stability testing.
Conclusions:
- The proper use of release data is essential for accurate stability studies.
- An identified ad hoc procedure offers a practical alternative to multiple imputation.
- Further research into optimized statistical methods for stability data is warranted.
Related Concept Videos
01:16Drug Product Stability
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
01:53RNA Stability
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:30Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...